Sasker Grootjans

Gent, VLG 9000, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

BiSim Tool: a binding simulation tool to aid and simplify ligand-binding assay design and development.

BiSim Tool: a binding simulation tool to aid and simplify ligand-binding assay design and development.

Journal: Bioanalysis
Published: April 17, 2024

Initiation and execution mechanisms of necroptosis: an overview.

Initiation and execution mechanisms of necroptosis: an overview.

Journal: Cell death and differentiation
Published: January 23, 2017

A real-time fluorometric method for the simultaneous detection of cell death type and rate.

A real-time fluorometric method for the simultaneous detection of cell death type and rate.

Journal: Nature protocols
Published: July 15, 2016

USP8 suppresses death receptor-mediated apoptosis by enhancing FLIPL stability.

USP8 suppresses death receptor-mediated apoptosis by enhancing FLIPL stability.

Journal: Oncogene
Published: December 11, 2015

Generation of a new Gateway-compatible inducible lentiviral vector platform allowing easy derivation of co-transduced cells.

Generation of a new Gateway-compatible inducible lentiviral vector platform allowing easy derivation of co-transduced cells.

Journal: BioTechniques
Published: July 17, 2015

Glutathione peroxidase 4 prevents necroptosis in mouse erythroid precursors.

Glutathione peroxidase 4 prevents necroptosis in mouse erythroid precursors.

Journal: Blood
Published: June 26, 2015

Depletion of RIPK3 or MLKL blocks TNF-driven necroptosis and switches towards a delayed RIPK1 kinase-dependent apoptosis.

Depletion of RIPK3 or MLKL blocks TNF-driven necroptosis and switches towards a delayed RIPK1 kinase-dependent apoptosis.

Journal: Cell death & disease
Published: October 31, 2013

RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition.

RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition.

Journal: Cell death and differentiation
Published: December 14, 2012

Necrostatin-1 blocks both RIPK1 and IDO: consequences for the study of cell death in experimental disease models.

Necrostatin-1 blocks both RIPK1 and IDO: consequences for the study of cell death in experimental disease models.

Journal: Cell death and differentiation
Published: December 01, 2012

Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models.

Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models.

Journal: Cell death & disease
Published: November 30, 2012

Determination of apoptotic and necrotic cell death in vitro and in vivo.

Determination of apoptotic and necrotic cell death in vitro and in vivo.

Journal: Methods (San Diego, Calif.)
Published: November 16, 2012

Sesquiterpene lactones as drugs with multiple targets in cancer treatment: focus on parthenolide.

Sesquiterpene lactones as drugs with multiple targets in cancer treatment: focus on parthenolide.

Journal: Anti-cancer drugs
Published: July 17, 2012
Showing 1-12 of 12

Last Updated: 09/26/2026